Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cholesterol-Lowering Program
Brain Injury Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Corporate Announcements
Investor Presentations
Financial Reports
Share Price Information
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Corporate Announcements
Investor Presentations
Financial Reports
Share Price Information
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2023
2022
2021
2020
14-Jan-2020
Updated Pro-forma - Financial Position and Commitments
14-Jan-2020
Securities Trading Policy
14-Jan-2020
Capital Structure and Restricted Securities
14-Jan-2020
Financial Statements Year End 30 June 2019
14-Jan-2020
Financial Statements Year End 30 June 2018
14-Jan-2020
Corporate Governance Statement
14-Jan-2020
Equity Incentive Plan
14-Jan-2020
Amended and Restated Certificate of Incorporation and Bylaws
14-Jan-2020
Supplementary Prospectus
14-Jan-2020
Prospectus
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next